GenMont Biotech Incorporation (TPE:3164)
18.05
+0.50 (2.85%)
Mar 10, 2026, 1:30 PM CST
-16.44% (1Y)
| Market Cap | 1.55B |
| Revenue (ttm) | 391.48M |
| Net Income (ttm) | 34.49M |
| Shares Out | 86.01M |
| EPS (ttm) | 0.39 |
| PE Ratio | 46.29 |
| Forward PE | n/a |
| Dividend | 0.80 (4.56%) |
| Ex-Dividend Date | Mar 27, 2025 |
| Volume | 57,368 |
| Average Volume | 72,587 |
| Open | 17.70 |
| Previous Close | 17.55 |
| Day's Range | 17.70 - 18.05 |
| 52-Week Range | 17.20 - 23.35 |
| Beta | 0.20 |
| RSI | 36.49 |
| Earnings Date | Mar 13, 2026 |